Myelodysplastic syndrome epidemiology and demographics: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}} {{NM}} | {{CMG}};{{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States.<ref name= | The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States.<ref name=cancergov>Incidence and mortality of myelodysplastic syndromes. National Cancer Institute 2015. http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq#link/_291_toc. Accessed on December 3, 2015</ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
===Incidence=== | ===Incidence=== | ||
The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States.<ref name= | The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States. MDS are diagnosed in slightly more than 10,000 people in the United States yearly.<ref name=cancergov>Incidence and mortality of myelodysplastic syndromes. National Cancer Institute 2015. http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq#link/_291_toc. Accessed on December 3, 2015</ref> | ||
===Age=== | ===Age=== | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with myelodysplastic syndrome than females.<ref name=cancergov>Incidence and mortality of myelodysplastic syndromes. National Cancer Institute 2015. http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq#link/_291_toc. Accessed on December 3, 2015</ref> | |||
===Race=== | ===Race=== | ||
Myelodysplastic syndrome usually affects individuals of the Caucasian race.<ref name=cancergov>Incidence and mortality of myelodysplastic syndromes. National Cancer Institute 2015. http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq#link/_291_toc. Accessed on December 3, 2015</ref> | |||
==References== | ==References== | ||
Revision as of 20:00, 3 December 2015
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome epidemiology and demographics |
|
FDA on Myelodysplastic syndrome epidemiology and demographics |
|
CDC on Myelodysplastic syndrome epidemiology and demographics |
|
Myelodysplastic syndrome epidemiology and demographics in the news |
|
Blogs on Myelodysplastic syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Myelodysplastic syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States.[1]
Epidemiology and Demographics
Prevalence
Incidence
The incidence of myelodysplastic syndrome is approximately 4.4 to 4.6 cases per 100,000 individuals in the United States. MDS are diagnosed in slightly more than 10,000 people in the United States yearly.[1]
Age
Gender
Males are more commonly affected with myelodysplastic syndrome than females.[1]
Race
Myelodysplastic syndrome usually affects individuals of the Caucasian race.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Incidence and mortality of myelodysplastic syndromes. National Cancer Institute 2015. http://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq#link/_291_toc. Accessed on December 3, 2015